Disorders of Hemostasis

Overview

Hemostasis refers to the physiological process that stops bleeding and maintains blood in a fluid state within the vascular system. Disorders of hemostasis can lead to either excessive clotting (thrombosis) or abnormal bleeding, both of which have significant clinical implications.

Three Stages of Hemostasis

Stages and Mechanisms

• Vascular Vasoconstriction: Immediate constriction of blood vessels reduces blood flow to the site of injury.

• Formation of the Platelet Plug: Platelets adhere to exposed collagen fibers at the site of vessel injury, forming a temporary plug to seal small breaks.

• Blood Coagulation (Fibrin Clot Formation): A cascade of coagulation factors converts soluble plasma protein fibrinogen into insoluble fibrin, creating a meshwork that stabilizes the platelet plug and forms a definitive clot.

After clot formation:

• Clot Retraction: Occurs 20–60 minutes later, squeezing serum from the clot and bringing the edges of the vessel together.

• Clot Dissolution (Fibrinolysis): Begins shortly after formation, allowing blood flow to be reestablished.

Categories of Disorders of Hemostasis

Thrombosis and Bleeding

• Thrombosis: Inappropriate formation of blood clots within the vascular system, which can obstruct blood flow and cause tissue damage.

• Bleeding: Failure of blood to clot in response to appropriate stimuli, leading to hemorrhage.

Requirements for Blood Clotting Process

Essential Components

• Platelets: Produced in the bone marrow; essential for plug formation and clot stabilization.

• Von Willebrand Factor (vWF): Generated by vessel endothelium; mediates platelet adhesion to exposed collagen and serves as a carrier for coagulation factor VIII.

• Clotting Factors: Synthesized in the liver, many require vitamin K as a cofactor.

Why Should Blood Clot?

Physiological Importance

• Integrity of Vascular Compartment: Prevents blood loss and maintains circulation.

• Infection Control: Clotting forms a barrier to prevent the spread of pathogens and acts as a scaffold for immune cells.

• Volume Maintenance: Stops bleeding and preserves blood volume.

• Oxygen Delivery: Prevents loss of oxygen-carrying red blood cells.

• Tissue Healing: Protects wounds from infection and supports tissue repair.

Coagulation Pathways

Intrinsic and Extrinsic Pathways

Both pathways converge at the same terminal steps:

• Calcium, Factors X and V, and Platelet Phospholipids: Combine to form prothrombin activator.

• Prothrombin Activator: Converts prothrombin to thrombin.

• Thrombin: Converts fibrinogen to fibrin, forming the insoluble clot.

Regulation of Blood Coagulation

Anticoagulant Mechanisms

• Antithrombin III: Inactivates coagulation factors and neutralizes thrombin; its action is accelerated by heparin.

• Protein C: Plasma protein that acts as an anticoagulant by inactivating factors V and VIII.

• Protein S: Accelerates the action of protein C.

• Plasmin: Breaks down fibrin into degradation products, acting as an anticoagulant.

Hypercoagulability States

Increased Risk of Thrombosis

• Arterial Thrombi: Associated with conditions that produce turbulent blood flow and increased platelet function (e.g., atherosclerosis, diabetes mellitus, smoking, elevated cholesterol).

• Venous Thrombi: Associated with stasis of blood flow and increased concentrations of coagulation factors (e.g., pregnancy, heart failure, malignancy, immobility).

Note: Venous thrombi most commonly develop in deep veins of the lower legs, presenting as pain and swelling.

Increased Platelet Function

Mechanisms and Causes

• Results in platelet adhesion, formation of platelet clots, and disruption of blood flow.

• Caused by disturbances in flow, endothelial damage, and increased sensitivity of platelets to aggregating factors.

• Possible causes: Inherited clotting disorders and prolonged immobility.

Atherosclerotic Plaques and Platelets

Role in Thrombosis

• Plaques disturb blood flow, causing endothelial damage and promoting platelet adherence.

• Adhered platelets release growth factors, leading to smooth muscle proliferation and atherosclerosis progression.

• Risk factors: Smoking, high cholesterol, hemodynamic stress, diabetes mellitus.

Causes of Bleeding

Platelet Deficiency and Dysfunction

• Decrease in Platelets: Severe depletion leads to spontaneous bleeding.

• Impaired Platelet Function: Deficiency causes bleeding in small vessels, characterized by petechiae and purpura.

Platelet Defects

Thrombocytopenia and Thrombocytopathia

• Thrombocytopenia: Platelet count <150,000/μL; causes include bone marrow failure (e.g., aplastic anemia), leukemia, and drug-induced destruction.

• Common symptoms: Frequent infections and easy bruising.

• Types: Drug-induced, idiopathic, and thrombotic thrombocytopenic purpura.

• Impaired Platelet Function (Thrombocytopathia): Disorders of platelet adhesion or aggregation (e.g., von Willebrand disease, uremia).

Manifestations of Thrombocytopenia

Clinical Signs

• Bleeding from mucous membranes: Nose, mouth, GI tract, uterine cavity.

• Petechiae: Pinpoint purplish-red spots, seen in platelet deficiency.

• Purpura: Purple areas of bruising.

• Most consistent findings: Petechiae, purpura, and fragile capillaries.

Coagulation and Vitamin K

Role of Vitamin K

• Vitamin K: Essential cofactor for synthesis of clotting factors; fat-soluble and synthesized by intestinal bacteria.

• Deficiency: Leads to production of inactive clotting factors and abnormal bleeding.

Coagulation Defects

Hereditary and Acquired Disorders

• Hereditary Disorders: Defective synthesis or genetic mutations affecting clotting factors.

• Hemophilia A: Factor VIII deficiency; inherited coagulation factor deficiency.

• Hemophilia B: Factor IX deficiency (Christmas disease); rare inherited disorder.

• Von Willebrand Disease: Deficiency or dysfunction of vWF.

• Prevention: Avoid trauma, NSAIDs, and use replacement factor therapy.

Vascular Disorders that Cause Bleeding

Non-Platelet Causes

• Hemorrhagic Telangiectasia: Autosomal dominant disorder with thin-walled, dilated capillaries and arterioles.

• Vitamin C Deficiency (Scurvy): Poor collagen synthesis leads to fragile vessel walls.

• Cushing Disease: Excess cortisol causes protein wasting and loss of vessel support.

• Senile Purpura: Bruising in elderly due to aging.

Disseminated Intravascular Coagulation (DIC)

Pathophysiology and Associated Conditions

• DIC: Widespread coagulation and bleeding due to massive activation of the coagulation cascade, generation of microthrombi, and consumption of clotting proteins and platelets, resulting in severe hemorrhage.

• Associated Conditions: Obstetric complications, cancers, infections, shock, trauma/surgery, hematologic conditions.

Summary Table: Key Disorders and Features

Example: Deep Vein Thrombosis (DVT)

Clinical Presentation: Pain and swelling in the lower leg, often associated with immobility or hypercoagulable states.

Additional info:

• Hemostasis and its disorders are relevant to microbiology due to their role in infection control and immune response.

• Vitamin K is produced by intestinal bacteria, linking microbiology and hemostasis.